UNSPSC 51285001: Clavulanate/ticarcillin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM113. This VA Drug Class (AM113) classifies this compound as belonging to the group EXTENDED SPECTRUM PENICILLINS.

UNSPSC 51285001 Clavulanate/ticarcillin is a Commodity code that, based on recent state and local solicitations, encompasses pharmaceutical products including generic multi-source drugs, over-the-counter medications, and emergency response medical supplies rather than this specific antibiotic combination alone. State and local governments are buying these products through a mix of issuing bodies: state health agencies, county public health departments, municipal fire and rescue divisions, and cooperative purchasing alliances serving multiple jurisdictions. The work involves sourcing, pricing, and delivering pharmaceuticals and medical supplies to public health facilities, emergency responders, and state employee health plans, with vendors typically required to establish relationships with authorized wholesalers, comply with FDA and Drug Supply Chain Security Act requirements, maintain specific insurance coverages, and meet delivery timelines and shelf-life standards.

Recent activity spans multiple regions, with Minnesota (through the MMCAP cooperative vehicle), Texas (HHS Commission), and Florida (Seminole County) showing the most visible recent procurement. Representative opportunities include the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026; the Texas HHS Commission RFI HHS0017013 for direct-to-manufacturer prescription program capabilities, issued April 3, 2026; the City of Tampa IFB 26P00145 for medical and first aid supplies for the Fire Department Rescue Division with a response deadline of March 13, 2026 and an estimated contract value of $700,000; and Seminole County, Florida IFB 60459723LAS for Naloxone and drug deactivation systems with a response deadline of July 26, 2023. The Tampa and Seminole County opportunities carry specific set-asides or preferences—Tampa designated the solicitation as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000.